What Is the Role for Cangrelor or GP IIB/IIIA Inhibitors in Today’s Practice?
Prospero B. Gogo, M.D., FSCAI, University of Vermont Medical Center, Burlington, VT
Prospero B. Gogo, M.D., FSCAI, University of Vermont Medical Center, Burlington, VT
Learning Objectives:
- Become familiar with emerging percutaneous ventricular support technologies and ongoing clinical trials.